DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Atrasentan is an investigational drug.
There have been 17 clinical trials for Atrasentan. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2006.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Kidney Diseases, and Diabetic Nephropathies. The leading clinical trial sponsors are Abbott, National Cancer Institute (NCI), and AbbVie (prior sponsor, Abbott).
Recent Clinical Trials for Atrasentan
|Atrasentan Spermatogenesis and Testicular Function||AbbVie||Phase 2|
|Study Of Diabetic Nephropathy With Atrasentan||AbbVie||Phase 3|
|A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy||AbbVie (prior sponsor, Abbott)||Phase 2|